Elektrofi

Elektrofi

生物技术研究

Boston,Massachusetts 7,260 位关注者

Formulating the Future of Biologics?

关于我们

Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, Hypercon?, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are headquartered in Boston and innovate globally. Formulating the Future of Biologics?. www.Elektrofi.com

网站
https://www.elektrofi.com
所属行业
生物技术研究
规模
51-200 人
总部
Boston,Massachusetts
类型
私人持股
创立
2016

地点

  • 主要

    25 Drydock Ave

    Floor 2

    US,Massachusetts,Boston,02210

    获取路线
  • 451 D street

    US,Massachusetts,Boston,02210

    获取路线
  • 75 Kneeland St

    US,Massachusetts,Boston,02111

    获取路线
  • One Kendall Square

    Building 200 Suite 2203

    US,MA,Cambridge,02142

    获取路线

Elektrofi员工

动态

相似主页

查看职位

融资

Elektrofi 共 4 轮

上一轮

C 轮

US$112,000,000.00

Crunchbase 上查看更多信息